Search Results 361-370 of 1084 for ⌛경산룸알바 O1O=8884=7003경산룸보도⌛

  1. A Study of Pancreatic Polypeptide Response in Patients with Diabetes Mellitus with and without Pancreatic Cancer - Mayo Clinic

    Phone: 507-284-8884; Email: intl.mcr@mayo.edu. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs ...

  2. A Study of the Influence of Central Obesity on the Esophageal Epithelial Barrier - Mayo Clinic

    Phone: 507-284-8884; Email: intl.mcr@mayo.edu. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs ...

  3. NIRS - Minimal Risk - Mayo Clinic

    Specifically, indices of muscle mitochondrial capacity, perfusive and diffusive oxygen conductance during exercise, and muscle microvascular function will be ...

  4. PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial

    Phone: 507-284-8884; Email: intl.mcr@mayo.edu. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs ...

  5. Care Processes and Person Centered Care of Patients with Neuroendocrine Tumors - Mayo Clinic

    About this study. Given that neuroendocrine tumors (NETs) represent a rare condition with complex treatment decisions and a lack of concrete guidance for ...

  6. Early Diuresis Following Colorectal Surgery - Mayo Clinic

    About this study. This study will assess if administration of a loop diuretic, specifically furosemide, to achieve euvolemia can safely reduce length of ...

  7. Heart Failure and Cardiothoracic Transplant Biorepository - Mayo Clinic

    This study is being done to develop a serum and tissue bank for future research of patients with heart failure, mechanical circulatory support and/or ...

  8. A Study of the Safety and Effectiveness of JZP-110 in the Treatment of Excessive Sleepiness in Patients with Narcolepsy - Mayo Clinic

    Phone: 507-284-8884; Email: intl.mcr@mayo.edu. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs ...

  9. Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis - Mayo Clinic

    The purpose of this study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to approximately 51 months ...

  10. Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH - Mayo Clinic

    This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH). It ...